ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIHCU(GBX) LSE
ETF TickerIUHC(USD) LSE
ETF TickerQDVG(EUR) F
ETF TickerIHCU.LS(GBX) CXE
ETF TickerIUHC.LS(USD) CXE
ETF TickerIUHCz(USD) CXE
ETF TickerQDVG.DE(EUR) CXE
ETF TickerIHCU.L(GBP) LSE
ETF TickerIUHC.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-04 (Thursday)50,529USD 36,522,361REGN holding decreased by -43960USD 36,522,3610USD -43,960 USD 722.8 USD 723.67
2025-12-03 (Wednesday)50,529USD 36,566,321REGN holding decreased by -926197USD 36,566,3210USD -926,197 USD 723.67 USD 742
2025-12-02 (Tuesday)50,529REGN holding decreased by -616USD 37,492,518REGN holding decreased by -871858USD 37,492,518-616USD -871,858 USD 742 USD 750.11
2025-12-01 (Monday)51,145REGN holding increased by 15USD 38,364,376REGN holding decreased by -1526739USD 38,364,37615USD -1,526,739 USD 750.11 USD 780.19
2025-11-28 (Friday)51,130REGN holding increased by 336USD 39,891,115REGN holding increased by 37635USD 39,891,115336USD 37,635 USD 780.19 USD 784.61
2025-11-27 (Thursday)50,794USD 39,853,480USD 39,853,4800USD 0 USD 784.61 USD 784.61
2025-11-26 (Wednesday)50,794REGN holding decreased by -112USD 39,853,480REGN holding decreased by -225832USD 39,853,480-112USD -225,832 USD 784.61 USD 787.32
2025-11-25 (Tuesday)50,906REGN holding increased by 112USD 40,079,312REGN holding increased by 1402221USD 40,079,312112USD 1,402,221 USD 787.32 USD 761.45
2025-11-24 (Monday)50,794REGN holding increased by 280USD 38,677,091REGN holding increased by 493558USD 38,677,091280USD 493,558 USD 761.45 USD 755.9
2025-11-21 (Friday)50,514USD 38,183,533REGN holding increased by 954715USD 38,183,5330USD 954,715 USD 755.9 USD 737
2025-11-20 (Thursday)50,514REGN holding increased by 56USD 37,228,818REGN holding increased by 1769458USD 37,228,81856USD 1,769,458 USD 737 USD 702.75
2025-11-19 (Wednesday)50,458USD 35,459,360REGN holding decreased by -1139846USD 35,459,3600USD -1,139,846 USD 702.75 USD 725.34
2025-11-18 (Tuesday)50,458USD 36,599,206REGN holding increased by 1061132USD 36,599,2060USD 1,061,132 USD 725.34 USD 704.31
2025-11-17 (Monday)50,458USD 35,538,074REGN holding increased by 545451USD 35,538,0740USD 545,451 USD 704.31 USD 693.5
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B43HR379

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02SELL-616 742.000* 646.32 Profit of 398,132 on sale
2025-12-01BUY15779.840748.210 751.373USD 11,271 645.87
2025-11-28BUY336 780.190* 645.28
2025-11-26SELL-112790.980777.000 778.398USD -87,181 644.05 Loss of -15,047 on sale
2025-11-26SELL-112790.980777.000 778.398USD -87,181 644.05 Loss of -15,047 on sale
2025-11-25BUY112790.570760.700 763.687USD 85,533 643.42
2025-11-24BUY280773.130756.640 758.289USD 212,321 642.89
2025-11-20BUY56 737.000* 641.97
2025-11-12SELL-224 681.720* 640.35 Profit of 143,438 on sale
2025-11-10BUY560665.990653.190 654.470USD 366,503 640.12
2025-11-06BUY56657.000641.260 642.834USD 35,999 640.01
2025-11-05SELL-56646.895628.000 629.890USD -35,274 639.99 Profit of 566 on sale
2025-11-04BUY56646.221625.140 627.248USD 35,126 640.05
2025-10-31BUY285659.760645.000 646.476USD 184,246 639.98
2025-10-30SELL-342664.000645.000 646.900USD -221,240 639.91 Loss of -2,390 on sale
2025-10-29SELL-114652.910659.980 659.273USD -75,157 639.85 Loss of -2,214 on sale
2025-10-28BUY108654.480655.700 655.578USD 70,802 639.78
2025-10-27SELL-114585.310586.150 586.066USD -66,812 640.04 Profit of 6,154 on sale
2025-10-22SELL-57584.740588.710 588.313USD -33,534 640.94 Profit of 3,000 on sale
2025-10-17SELL-228578.050579.040 578.941USD -131,999 641.89 Profit of 14,353 on sale
2025-10-16BUY285569.170589.080 587.089USD 167,320 642.26
2025-10-15BUY399576.420584.870 584.025USD 233,026 642.59
2025-10-14BUY57572.600576.180 575.822USD 32,822 642.95
2025-10-06BUY285585.480603.650 601.833USD 171,522 643.56
2025-10-03BUY112600.000618.010 616.209USD 69,015 643.78
2025-10-02BUY56600.000605.410 604.869USD 33,873 644.01
2025-10-01BUY326599.940615.390 613.845USD 200,113 644.24
2025-09-24SELL-716576.980577.980 577.880USD -413,762 646.40 Profit of 49,060 on sale
2025-09-18BUY57598.710600.000 599.871USD 34,193 646.66
2025-09-11BUY57568.200570.760 570.504USD 32,519 647.82
2025-09-10BUY57555.830560.000 559.583USD 31,896 648.33
2025-08-28BUY57579.610590.960 589.825USD 33,620 649.73
2025-08-26BUY228587.650588.100 588.055USD 134,077 650.44
2025-08-20BUY114591.010596.920 596.329USD 67,982 651.90
2025-08-19BUY57571.780581.690 580.699USD 33,100 652.37
2025-07-17SELL-58550.000554.480 554.032USD -32,134 654.83 Profit of 5,846 on sale
2025-07-15SELL-232547.960574.750 572.071USD -132,720 656.12 Profit of 19,500 on sale
2025-07-14SELL-580570.590575.130 574.676USD -333,312 656.64 Profit of 47,541 on sale
2025-07-09SELL-58552.580558.380 557.800USD -32,352 658.44 Profit of 5,837 on sale
2025-07-07SELL-116538.110547.590 546.642USD -63,410 659.90 Profit of 13,138 on sale
2025-07-02BUY58547.740551.500 551.124USD 31,965 662.06
2025-06-24SELL-986522.270527.450 526.932USD -519,555 666.70 Profit of 137,811 on sale
2025-06-23BUY58511.920516.180 515.754USD 29,914 667.73
2025-06-20SELL-491509.720521.310 520.151USD -255,394 668.79 Profit of 72,983 on sale
2025-06-18SELL-58513.580519.170 518.611USD -30,079 670.90 Profit of 8,833 on sale
2025-06-17BUY696508.860523.010 521.595USD 363,030 672.01
2025-06-13SELL-116529.240529.550 529.519USD -61,424 674.04 Profit of 16,765 on sale
2025-06-11SELL-58518.600528.370 527.393USD -30,589 676.21 Profit of 8,631 on sale
2025-06-10SELL-116523.530529.990 529.344USD -61,404 677.29 Profit of 17,162 on sale
2025-06-09SELL-174517.600518.270 518.203USD -90,167 678.43 Profit of 27,880 on sale
2025-05-21SELL-57604.620617.520 616.230USD -35,125 691.90 Profit of 4,313 on sale
2025-05-20SELL-114614.790615.450 615.384USD -70,154 692.51 Profit of 8,793 on sale
2025-05-15SELL-171584.990585.260 585.233USD -100,075 694.97 Profit of 18,765 on sale
2025-05-14SELL-171571.360580.560 579.640USD -99,118 695.98 Profit of 19,894 on sale
2025-05-13BUY57574.160575.050 574.961USD 32,773 696.99
2025-05-09SELL-57527.780552.840 550.334USD -31,369 699.43 Profit of 8,498 on sale
2025-05-08BUY114547.670552.570 552.080USD 62,937 700.72
2025-05-01BUY114590.000593.930 593.537USD 67,663 705.89
2025-04-24SELL-57599.760601.280 601.128USD -34,264 710.97 Profit of 6,261 on sale
2025-04-23BUY171587.850603.770 602.178USD 102,972 712.12
2025-04-15SELL-57557.910575.200 573.471USD -32,688 720.96 Profit of 8,407 on sale
2025-04-10SELL-114546.390571.990 569.430USD -64,915 725.97 Profit of 17,845 on sale
2025-04-08SELL-57556.810586.030 583.108USD -33,237 729.29 Profit of 8,332 on sale
2025-04-07SELL-57572.780591.540 589.664USD -33,611 730.93 Profit of 8,052 on sale
2025-04-04SELL-114573.450612.990 609.036USD -69,430 732.61 Profit of 14,087 on sale
2025-04-02BUY57625.600628.000 627.760USD 35,782 733.76
2025-04-01BUY513617.000641.240 638.816USD 327,713 735.03
2025-03-31SELL-342634.230640.720 640.071USD -218,904 736.14 Profit of 32,854 on sale
2025-03-28BUY57637.360642.970 642.409USD 36,617 737.23
2025-03-26SELL-36640.140644.000 643.614USD -23,170 739.49 Profit of 3,451 on sale
2025-03-21BUY696658.480661.000 660.748USD 459,881 742.60
2025-03-20BUY228662.620674.830 673.609USD 153,583 743.56
2025-03-17SELL-57678.420679.830 679.689USD -38,742 746.21 Profit of 3,792 on sale
2025-03-12SELL-42689.500712.460 710.164USD -29,827 748.80 Profit of 1,623 on sale
2025-03-07BUY57707.510729.750 727.526USD 41,469 749.81
2025-02-28SELL-171698.740708.580 707.596USD -120,999 753.37 Profit of 7,827 on sale
2025-02-25BUY570723.470739.000 737.447USD 420,345 755.24
2025-02-20BUY399696.020703.140 702.428USD 280,269 757.64
2025-02-19BUY171685.660688.670 688.369USD 117,711 758.76
2025-02-18BUY114680.000689.950 688.955USD 78,541 760.01
2025-02-13BUY285674.270677.690 677.348USD 193,044 764.32
2025-02-04BUY228697.050709.980 708.687USD 161,581 773.47
2025-01-31BUY57672.980688.000 686.498USD 39,130 777.53
2025-01-29BUY57687.270697.570 696.540USD 39,703 781.30
2025-01-27BUY114684.710698.450 697.076USD 79,467 785.37
2025-01-24BUY57675.790693.840 692.035USD 39,446 787.76
2025-01-22BUY228680.030699.880 697.895USD 159,120 792.32
2024-12-10SELL-57778.500791.490 790.191USD -45,041 820.13 Profit of 1,706 on sale
2024-12-09SELL-1,482788.000800.990 799.691USD -1,185,142 821.13 Profit of 31,774 on sale
2024-12-03SELL-684749.570770.000 767.957USD -525,283 829.52 Profit of 42,107 on sale
2024-12-02SELL-285762.340763.890 763.735USD -217,664 832.00 Profit of 19,457 on sale
2024-11-29SELL-57750.220754.510 754.081USD -42,983 835.15 Profit of 4,621 on sale
2024-11-22SELL-570738.000751.400 750.060USD -427,534 855.41 Profit of 60,050 on sale
2024-11-21SELL-285744.500757.560 756.254USD -215,532 860.96 Profit of 29,840 on sale
2024-11-20BUY456743.350750.690 749.956USD 341,980 867.15
2024-11-18SELL-684762.000762.700 762.630USD -521,639 880.54 Profit of 80,650 on sale
2024-11-11BUY513825.680834.420 833.546USD 427,609 888.17
2024-11-08SELL-1,824828.420830.730 830.499USD -1,514,830 892.43 Profit of 112,970 on sale
2024-11-07SELL-114824.480832.530 831.725USD -94,817 897.66 Profit of 7,517 on sale
2024-11-01SELL-114843.600862.000 860.160USD -98,058 927.90 Profit of 7,722 on sale
2024-10-31SELL-228838.200883.150 878.655USD -200,333 939.11 Profit of 13,784 on sale
2024-10-30BUY57922.790935.860 934.553USD 53,270 941.44
2024-10-29BUY342927.330932.380 931.875USD 318,701 943.79
2024-10-28SELL-171928.610943.270 941.804USD -161,048 946.83 Profit of 859 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy